Possible Bearish Signals With Hims & Hers Health Insiders Disposing Stock
Possible Bearish Signals With Hims & Hers Health Insiders Disposing Stock
Over the past year, many Hims & Hers Health, Inc. (NYSE:HIMS) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, if numerous insiders are selling, shareholders should investigate more.
过去一年中,许多大家病假和她们的健康公司(NYSE:HIMS)内部的人出售了公司的重要股份,这可能引起了投资者的兴趣。然而,了解内部人士是否在购买时通常更有帮助,在评估内部交易时,因为内部出售有各种各样的解释。但是,如果许多内部人员都在出售,股东应该进行更多的调查。
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
尽管在长期投资中内部交易并不是最重要的事情,但从逻辑上讲,您应该关注内部人员是否买入或出售股票。
Hims & Hers Health Insider Transactions Over The Last Year
在过去的十二个月中,最大的单笔交易是由董事会独立董事David Wells出售价值340万美元的股票,每股价格为13.16美元。这意味着一个内部人士正在以略低于当前价格(21.72美元)的价格出售股票。当内部人士以低于当前价格的价格出售股票时,这意味着他们认为较低的价格是公正的。这让我们想知道他们对(更高的)最近估值持什么看法。请注意,卖家可能有各种出售股票的原因,因此我们不知道他们对股票价格有何看法。我们注意到,最大的单笔销售是David Wells持股的64%。
In the last twelve months, the biggest single sale by an insider was when the Lead Independent Director, David Wells, sold US$3.4m worth of shares at a price of US$13.16 per share. That means that an insider was selling shares at slightly below the current price (US$21.72). When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was 64% of David Wells's holding.
过去一年中,我们看到大量Hims & Hers Health公司的内部人士出售了股票,而不是购买。下面的图表显示了过去一年内公司和个人的内部交易。如果您想知道谁以多少价钱何时出售,只需点击下面的图表即可!
Over the last year we saw more insider selling of Hims & Hers Health shares, than buying. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
纽交所:HIMS内部交易成交量2024年7月14日
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240714/0-abbaea58bf551a0ea540cf62210bffd1-0-a94767882269c717d2b6da885136f04a.png/big)
If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.
如果您和我一样,您就不会错过这个免费的小盘股票列表,这些股票不仅被内部人士购买,而且估值也很有吸引力。
Insiders At Hims & Hers Health Have Bought Stock Recently
在过去的三个月中,我们看到Hims & Hers Health的内部购买明显超过销售。我们可以看到,Christopher Payne内部人士为公司支付200万美元购买了股票。但是,我们看到了价值21万美元的内部销售。购买超过出售,这表明内部人士可能认为公司未来会表现良好。
Over the last three months, we've seen significantly more insider buying, than insider selling, at Hims & Hers Health. We can see that insider Christopher Payne paid US$2.0m for shares in the company. But we did see insider selling worth US$210k. The buying outweighs the selling, which suggests that insiders may believe the company will do well in the future.
Hims & Hers Health是否拥有高持股份额的内部所有权?
Does Hims & Hers Health Boast High Insider Ownership?
我喜欢看看内部人士在公司中拥有的股份,以帮助我了解他们与内部人士的利益是否相一致。我们通常希望看到较高水平的内部所有权。很高兴看到Hims & Hers Health的内部人士拥有该公司14%的股份,价值6500万美元左右。我喜欢看到这种内部所有权水平,因为这增加了管理层考虑股东最佳利益的机会。
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. It's great to see that Hims & Hers Health insiders own 14% of the company, worth about US$650m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
那么,Hims & Hers Health的内部交易表示什么?
So What Do The Hims & Hers Health Insider Transactions Indicate?
看到最近的内部购买是好事。但是,我们无法对过去12个月的交易说出同样的话。高水平的内部所有权以及内部人士最近的购买表明他们的利益相一致且乐观。除了了解正在进行的内部交易外,还有助于确定Hims & Hers Health面临的风险。您将会发现,我们发现了Hims & Hers Health的2个警示信号,建议您查看。
It is good to see the recent insider purchase. But we can't say the same for the transactions over the last 12 months. The high levels of insider ownership, and the recent buying by an insider suggests they are well aligned and optimistic. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Hims & Hers Health. You'd be interested to know, that we found 2 warning signs for Hims & Hers Health and we suggest you have a look.
看到最近的内部购买是好事,但过去12个月的交易情况却不尽如人意。高水平的内部股权和内部人最近的购买表明他们的利益保持一致,持乐观态度。除了了解正在进行的内部交易,找出妳我健康公司面临的风险也是很有益的。您会感兴趣知道,我们发现了2个妳我健康公司的警示信号,我们建议您进行查看。
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
如果你想查看其他公司——那些具有开多净资产收益率和低负债的有趣公司的免费清单——那么不要错过这个机会。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?关注内容?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有反馈? 对内容感到担忧? 请直接与我们联系。 或者,发送电子邮件至editorial-team@simplywallst.com。